FIG 4.
Treatment comparisons of immune checkpoint inhibitors (ICIs) versus historic controls. Median survival is represented by the dashed lines and reported in the legend. 1L, first line; 2L+, second or subsequent line; OS, overall survival; NSCLC, non–small-cell lung cancer; RCC, renal cell carcinoma.